Paper8690806
Induction of circulating myelin basic protein and proteolipid protein-specific transforming growth factor-beta1-secreting Th3 T cells by oral administration of myelin in multiple sclerosis patients.
Fukaura H and 5 others. J Clin Invest, 1996. Cited by 351 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. Induction of circulating myelin basic protein and proteolipid protein-specific transforming growth factor-beta1-secreting Th3 T cells by oral administration of myelin in multiple sclerosis patients. Papers, record 8690806. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/8690806
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Induction of circulating myelin basic protein and proteolipid protein-specific transforming growth factor-beta1-secreting Th3 T cells by oral administration of myelin in multiple sclerosis patients.
- PubMed
- Publication types
- Clinical Trial, Controlled Clinical Trial, Journal Article, Research Support, Non-U.S. Gov't, Research Support, U.S. Gov't, P.H.S.
- PubMed
Topics15
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Autoantigens | Major topic |
| Multiple Sclerosis | Major topic |
| Myelin Proteins | Major topic |
| T-Lymphocytes, Helper-Inducer | Major topic |
| Transforming Growth Factor beta | Major topic |
| Administration, Oral | |
| Clinical Trials as Topic | |
| Follow-Up Studies | |
| Humans | |
| Immune Tolerance | |
| Interferon-gamma | |
| Interleukin-4 | |
| Myelin Basic Protein | |
| Myelin Proteolipid Protein | |
| Recurrence |
Source PubMed
Grants3
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by | Source |
|---|---|---|---|---|---|
| AR 43220 | NIAMS NIH HHS | United States | P01AR043220 | PubMed and NIH | NIH RePORTER |
| R01-NS-29352 | NINDS NIH HHS | United States | R01NS029352 | PubMed and NIH | NIH RePORTER |
| R01-NS24247 | NINDS NIH HHS | United States | R01NS024247 | PubMed and NIH | NIH RePORTER |
References33
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 57,115 | Basis of microheterogeneity of myelin basic protein. | J Biol Chem | 1976 | https://conductscience.org/library/papers/57115 | PubMed |
| 2 | 8,820,272 | The expanding universe of T-cell subsets: Th1, Th2 and more. | Immunol Today | 1996 | https://conductscience.org/library/papers/8820272 | PubMed |
| 3 | 2,413,363 | T-cell clones specific for myelin basic protein induce chronic relapsing paralysis and demyelination. | Nature | 1985 | https://conductscience.org/library/papers/2413363 | PubMed |
| 4 | 3,463,976 | Suppression of type II collagen-induced arthritis by intragastric administration of soluble type II collagen. | Proc Natl Acad Sci U S A | 1986 | https://conductscience.org/library/papers/3463976 | PubMed |
| 5 | 3,791,692 | Gastric administration of type II collagen delays the onset and severity of collagen-induced arthritis in rats. | Clin Exp Immunol | 1986 | https://conductscience.org/library/papers/3791692 | PubMed |
| 6 | 2,447,178 | Suppression of experimental autoimmune encephalomyelitis by oral administration of myelin basic protein and its fragments. | J Immunol | 1988 | https://conductscience.org/library/papers/2447178 | PubMed |
| 7 | 3,257,990 | Myelin proteolipid protein-induced experimental allergic encephalomyelitis. Variations of disease expression in different strains of mice. | J Immunol | 1988 | https://conductscience.org/library/papers/3257990 | PubMed |
| 8 | 2,451,570 | Suppression of experimental autoimmune encephalomyelitis by the oral administration of myelin basic protein. | Cell Immunol | 1988 | https://conductscience.org/library/papers/2451570 | PubMed |
| 9 | 2,478,145 | Inflammatory and immunomodulatory roles of TGF-beta. | Immunol Today | 1989 | https://conductscience.org/library/papers/2478145 | PubMed |
| 10 | 2,295,822 | Mechanism for transforming growth factor beta and IL-2 enhancement of IgA expression in lipopolysaccharide-stimulated B cell cultures. | J Immunol | 1990 | https://conductscience.org/library/papers/2295822 | PubMed |
| 11 | 2,137,841 | Inhibition of S-antigen induced experimental autoimmune uveoretinitis by oral induction of tolerance with S-antigen. | J Immunol | 1990 | https://conductscience.org/library/papers/2137841 | PubMed |
| 12 | 2,120,332 | Suppression of adjuvant arthritis in Lewis rats by oral administration of type II collagen. | J Immunol | 1990 | https://conductscience.org/library/papers/2120332 | PubMed |
| 13 | 1,704,424 | Fatty acid composition of human myelin proteolipid protein in peroxisomal disorders. | J Neurochem | 1991 | https://conductscience.org/library/papers/1704424 | PubMed |
| 14 | 1,717,550 | Oral tolerance in experimental autoimmune encephalomyelitis. III. Evidence for clonal anergy. | J Immunol | 1991 | https://conductscience.org/library/papers/1717550 | PubMed |
| 15 | 1,717,632 | Antigen-driven bystander suppression after oral administration of antigens. | J Exp Med | 1991 | https://conductscience.org/library/papers/1717632 | PubMed |
| 16 | 1,946,445 | Suppression of diabetes in nonobese diabetic mice by oral administration of porcine insulin. | Proc Natl Acad Sci U S A | 1991 | https://conductscience.org/library/papers/1946445 | PubMed |
| 17 | 1,370,356 | Suppressor T cells generated by oral tolerization to myelin basic protein suppress both in vitro and in vivo immune responses by the release of transforming growth factor beta after antigen-specific triggering. | Proc Natl Acad Sci U S A | 1992 | https://conductscience.org/library/papers/1370356 | PubMed |
| 18 | 1,377,368 | Spreading of T-cell autoimmunity to cryptic determinants of an autoantigen. | Nature | 1992 | https://conductscience.org/library/papers/1377368 | PubMed |
| 19 | 1,383,385 | Oral tolerance to myelin basic protein and natural recovery from experimental autoimmune encephalomyelitis are associated with downregulation of inflammatory cytokines and differential upregulation of transforming growth factor beta, interleukin 4, and prostaglandin E expression in the brain. | J Exp Med | 1992 | https://conductscience.org/library/papers/1383385 | PubMed |
| 20 | 7,680,493 | Double-blind pilot trial of oral tolerization with myelin antigens in multiple sclerosis. | Science | 1993 | https://conductscience.org/library/papers/7680493 | PubMed |
Cited by111
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 351 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 41,828,510 | AAV Gene Therapy for MPS IVA with Induction of Immune Tolerance via Oral Administration of Epitope Peptides of N-Acetylgalactosamine-6-sulfate Sulfatase. | Int J Mol Sci | 2026 | https://conductscience.org/library/papers/41828510 | PubMed |
| 39,362,875 | Evolving understanding of autoimmune mechanisms and new therapeutic strategies of autoimmune disorders. | Signal Transduct Target Ther | 2024 | https://conductscience.org/library/papers/39362875 | PubMed |
| 37,900,596 | Bibliometric analysis of global research trends on regulatory T cells in neurological diseases. | Front Neurol | 2023 | https://conductscience.org/library/papers/37900596 | PubMed |
| 37,283,612 | Recombinant MBP-pσ1 expressed in soybean seeds delays onset and reduces developing disease in an animal model of multiple sclerosis. | Plant Biotechnol (Tokyo) | 2022 | https://conductscience.org/library/papers/37283612 | PubMed |
| 36,289,525 | Concanavalin A as a promising lectin-based anti-cancer agent: the molecular mechanisms and therapeutic potential. | Cell Commun Signal | 2022 | https://conductscience.org/library/papers/36289525 | PubMed |
| 35,919,740 | Advancement of antigen-specific immunotherapy: knowledge transfer between allergy and autoimmunity. | Immunother Adv | 2021 | https://conductscience.org/library/papers/35919740 | PubMed |
| 35,919,733 | Oral tolerance as antigen-specific immunotherapy. | Immunother Adv | 2021 | https://conductscience.org/library/papers/35919733 | PubMed |
| 35,087,799 | Electrical Stimulation for Immune Modulation in Cancer Treatments. | Front Bioeng Biotechnol | 2021 | https://conductscience.org/library/papers/35087799 | PubMed |
| 35,003,073 | Role of Exercise Intensity on Th1/Th2 Immune Modulations During the COVID-19 Pandemic. | Front Immunol | 2021 | https://conductscience.org/library/papers/35003073 | PubMed |
| 33,679,769 | Antigen-Specific Treatment Modalities in MS: The Past, the Present, and the Future. | Front Immunol | 2021 | https://conductscience.org/library/papers/33679769 | PubMed |
| 33,248,367 | Role of orally induced regulatory T cells in immunotherapy and tolerance. | Cell Immunol | 2021 | https://conductscience.org/library/papers/33248367 | PubMed |
| 32,617,181 | Atheroprotective nasal immunization with a heat shock protein 60 peptide from Porphyromonas gingivalis. | J Periodontal Implant Sci | 2020 | https://conductscience.org/library/papers/32617181 | PubMed |
| 31,758,298 | Molecular characterization and immune protection of an AN1-like zinc finger protein of Eimeria tenella. | Parasitol Res | 2020 | https://conductscience.org/library/papers/31758298 | PubMed |
| 31,134,056 | The Tolerogenic Function of Regulatory T Cells in Pregnancy and Cancer. | Front Immunol | 2019 | https://conductscience.org/library/papers/31134056 | PubMed |
| 30,531,969 | PDL2+ CD11b+ dermal dendritic cells capture topical antigen through hair follicles to prime LAP+ Tregs. | Nat Commun | 2018 | https://conductscience.org/library/papers/30531969 | PubMed |
| 30,082,532 | Immune Tolerance Therapy: A New Method for Treatment of Traumatic Brain Injury. | Chin Med J (Engl) | 2018 | https://conductscience.org/library/papers/30082532 | PubMed |
| 29,491,358 | To respond or not to respond - a personal perspective of intestinal tolerance. | Nat Rev Immunol | 2018 | https://conductscience.org/library/papers/29491358 | PubMed |
| 28,454,277 | Monocyte-derived dendritic cells from patients with cervical intraepithelial lesions. | Oncol Lett | 2017 | https://conductscience.org/library/papers/28454277 | PubMed |
| 27,417,020 | Epicutaneous immunotherapy induces gastrointestinal LAP+ regulatory T cells and prevents food-induced anaphylaxis. | J Allergy Clin Immunol | 2017 | https://conductscience.org/library/papers/27417020 | PubMed |
| 27,154,631 | Induction of regulatory T-cells from memory T-cells is perturbed during acute exacerbation of multiple sclerosis. | Clin Immunol | 2016 | https://conductscience.org/library/papers/27154631 | PubMed |
Genes5
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| IFNG | 3,458 | PubTator's text mining | https://conductscience.org/library/genes/3458 | NCBI Gene |
| IL4 | 3,565 | PubTator's text mining | https://conductscience.org/library/genes/3565 | NCBI Gene |
| MBP | 4,155 | PubTator's text mining | https://conductscience.org/library/genes/4155 | NCBI Gene |
| PLP1 | 5,354 | PubTator's text mining | https://conductscience.org/library/genes/5354 | NCBI Gene |
| TGFB1 | 7,040 | PubTator's text mining | https://conductscience.org/library/genes/7040 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/8690806
GET https://conductscience.org/api/papers/v1/8690806/references?page=2